Fasken Martineau DuMoulin LLP assisted NuChem Sciences inc. on the matter. Sygnature Discovery completed major acquisition of NuChem Sciences, one of North America’s largest drug discovery...
Sygnature Discovery’s Acquisition of NuChem Sciences
NuChem Sciences’ $37.6 Million Acquisition of OmegaChem
Fasken Martineau DuMoulin LLP represented NuChem and its shareholders in connection with this acquisition. On August 10, 2021, NuChem Sciences, a contract medical research company, completed...